Liposome-Encapsulated Daunorubicin-Cytarabine Clinical Trials

A listing of Liposome-Encapsulated Daunorubicin-Cytarabine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

This phase III trial compares standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubicin, cytarabine, and gemtuzumab ozogamicin, work in different ways to stop the growth of cancer cells, either by …

anthracycline
allogeneic hematopoietic stem cell transplant
cancer
mitoxantrone
leukemic cells
  • 0 views
  • 2 annotations
  • 19 Feb, 2024
  • 1 location
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine (CPX-351) works in treating patients with secondary acute myeloid leukemia who are younger than 60 years old.

acute myeloid leukemia with myelodysplasia-related changes
cancer
treatment related aml
myelodysplastic syndrome acute myeloid leukemia
myelodysplasia
  • 0 views
  • 19 Feb, 2024
  • 1 location